A few weeks ago I heard a talk by Professor Ulf Landegren from Uppsala University about innovation and commercialization of research. Landegren himself has developed innovative molecular tools for measuring DNA, RNA and proteins in blood and tissues, resulting in a large number of patents and companies including Olink (www.olink.com).
Landegren also delved on how governments and universities facilitate innovation and presented a figure that shows proportion of GDP spent on R&D in relation to number of scientists and engineers. The figure was taken from an article in Nature Immunology (Kollias and Lambris, 2015) in which Greek researchers pointed out everything that did not work in Greece in general and in Greek research policies in particular. They mention, among other things, politically driven research with no clear strategy, no real evaluation of money spent, and when evaluations are performed they lead nowhere.
Research and development (R&D) versus scientists / engineers per million. Size of the circle reflects the size of the amounts used for R&D.
Not surprisingly, Norway spends the lowest amount of money on R&D compared to our Nordic neighbors, despite broad political consensus that we should spend more. After all, we are “one of the richest countries in the world.” Another striking feature that puts us on what Landegren thinks is the wrong part of the ball park (with Greece), is that Norway has a high proportion of researchers per million inhabitants compared to available R&D funds. At first glance it may seem good to have many scientists, but limited research and innovation funds allocated to many scientists might produce mediocre results in many areas instead of groundbreaking research that can be commercialized and create new industries and jobs. In the opposite end of the field you find Israel as an outlier with a 4.3% share of GDP spent on R&D spread over about 1600 researchers per million. Perhaps there is a connection between this research policy and the fact that Israel produces more high-tech start ups than countries like Britain, Canada and China. Maybe we have something to learn by looking to Israel and our Nordic neighbors.
I wish you all a good weekend!
Invitation to user training in EcoExposure – reminder
UiB and K2 will use EcoExposure as exposure registry for staff and students who may be exposed to substances that can cause serious illnesses over time. Bente-Lise Lillebø from the HSE department will visit K2 and teach us how we as users must register exposure.
Time: Thursday, 23 June, 12.30 to 13.30
Location: Auditorium 4, BB-building.
Time: Wednesday 22nd, Kl: 13:30- 15:00
Place: Meeting room of 9th floor of new laboratory building
The Advisory Group (AG) report for Social Challenges in health, demographic change and quality of life (SC1) is now available. The report is advisory for the design of the work programme for SC1 for the period 2018-2020. This is described in the preface. The AG report will be used as the basis for discussions at the meeting between the AG and the programme committee on 21 September 2016. The programme comittee will provide input on behalf of Norway. Good suggestions paves the way for this.
Input on the report can be sent to Kristin Andersen (firstname.lastname@example.org), no later than Thursday 30 June. Suggestions and comments must be entered in the attached form.
AG advice report 2018-2020
Systec autoclaves in the Laboratory building are undergoing service in week 25 (20.-24.June, 2016). This means the machines will be out of order for a few days. Users are advised to check the logbook prior to starting the sterilization process in order to make sure the autoclave is back to being fully functional.
Postdoctoral Programme at the Faculty of Medicine and Dentistry
This autumn the Faculty of Medicine and Dentistry will initiate an educational programme for postdoctoral fellows. There is a need to provide the post-docs with expertise that will be important both for their future work in academia and in other jobs. An educational programme will increase the postdoctors’ expertise, help to create a community among post-docs and make the postdoctoral positions at the faculty more attractive. The programme will comprise different modules.
You are hereby invited to an information meeting about the programme, where there will be further information about the contents and scope. Note that this applies to all postdoctoral fellows, not only those who are funded by UoB.
Time: Thursday 23 June 2016 kl. 11-12
Venue: Birkhaugsalen (3. floor, Sentralblokken)
We encourage everyone to attend – this is exciting !!
Have you considered to apply for funding from FORNY2020 or BIOTEK2021?
In 2015, the Norwegian Research Council allocated 300 million NOK through the funding programs FORNY2020 and BIOTEK2021. The programs target research projects with a commercial potential, and can be used to conduct testing, upscaling and continuation etc. The next deadline is 7th of September.
The Norwegian Research Council visits Bergen 21. of June to inform researchers about FORNY2020 and BIOTEK2021. This is an opportunity to get information and ask questions to advisers with first-hand information about the programs. Join our info meeting to get all the information you need. Continue reading
Attached you will find a letter from the Faculty with information regarding nominations from MOF as well as the actual announcement (both in Norwegian).
Letter from the Faculty
Based on last week’s search for “Department of Clinical Science AND Bergen”. If you have publications which are not covered by this search, send the reference to email@example.com.
In sepsis, 88% of bacteraemia patients are discriminated by unsupervised hierarchical cluster analysis of 5 inflammatory mediators.
Mosevoll KA, Reikvam H, Fanebust HR, Flaaten H, Skrede S, Bruserud Ø.
Intensive Care Med Exp. 2015 Dec;3(Suppl 1):A881.
RareVariantVis: new tool for visualization of causative variants in rare monogenic disorders using whole genome sequencing data.
Stokowy T, Garbulowski M, Fiskerstrand T, Holdhus R, Labun K, Sztromwasser P, Gilissen C, Hoischen A, Houge G, Petersen K, Jonassen I, Steen VM.
Bioinformatics. 2016 Jun 10.
Short Stature: Comparison of WHO and National Growth Standards/References for Height.
Christesen HT, Pedersen BT, Pournara E, Petit IO, Júlíusson PB.
PLoS One. 2016 Jun 9;11(6):e0157277. d
Need of education for dry powder inhaler storage and retention – a patient-reported survey.
Norderud Lærum B, Telg G, Stratelis G.
Multidiscip Respir Med. 2016 Jun 8;11:21
Prognostic significance of S100A4 expression in stage II and III colorectal cancer: results from a population-based series and a randomized phase III study on adjuvant chemotherapy.
Boye K, Jacob H, Frikstad KM, Nesland JM, Maelandsmo GM, Dahl O, Nesbakken A, Flatmark K.
Cancer Med. 2016 Jun 8.
Disease activity is associated with reduced left ventricular systolic myocardial function in patients with rheumatoid arthritis.
Midtbø H, Semb AG, Matre K, Kvien TK, Gerdts E.
Ann Rheum Dis. 2016 Jun 7.
Regeneration of pancreatic insulin-producing cells by in situ adaptive cell conversion.
Chera S, Herrera PL.
Curr Opin Genet Dev. 2016 Jun 3;40:1-10.
Here you will find this weeks application deadlines: Continue reading